Gamma Ventral Capsulotomy for Obsessive Compulsive Disorder: A Placebo-Controlled, Double-Blind Clinical Trial

被引：0
|
作者：
Lopes, Antonio C. [1 ]
Batistuzzo, Marcelo C. [1 ]
Canteras, Miguel M. [2 ]
Joaquim, Marines A. [1 ]
de Mathis, Maria E. [1 ]
Hoexter, Marcelo Q. [1 ]
Greenberg, Benjamin D. [3 ]
Noren, Georg [4 ]
Rasmussen, Steven A. [3 ]
Shavitt, Roseli G. [1 ]
Miguel, Euripedes C. [1 ]
机构：
[1] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil
[2] Santa Paula Hosp, Inst Neurol Radiosurg, Sao Paulo, Brazil
[3] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA
[4] Brown Univ, Dept Clin Neurosci Neurosurg, Warren Alpert Med Sch, Providence, RI 02912 USA
来源：
BIOLOGICAL PSYCHIATRY | 2013年 / 73卷 / 09期
关键词：
Obsessive-compulsive disorder; Radiosurgery; Placebo effect; Randomized Controlled Trial; Neurosurgery;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
103
引用
收藏
页码：33S / 33S
页数：1
相关论文
共 50 条
  • [1] A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder
    Hollander, E
    Kaplan, A
    Stahl, SM
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2003, 4 (01): : 30 - 34
  • [2] Tolcapone in Obsessive Compulsive Disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial
    Grant, Jon
    Chamberlain, Samuel
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 312 - 313
  • [3] Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trial
    Mowla, Arash
    Ghaedsharaf, Mehrnoosh
    CNS SPECTRUMS, 2020, 25 (04) : 552 - 556
  • [4] Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial
    Grant, Jon E.
    Hook, Roxanne
    Valle, Stephanie
    Chesivoir, Eve
    Chamberlain, Samuel R.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (05) : 225 - 229
  • [5] OBSESSIVE-COMPULSIVE DISORDER - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CLOMIPRAMINE IN 27 PATIENTS
    JENIKE, MA
    BAER, L
    SUMMERGRAD, P
    WEILBURG, JB
    HOLLAND, A
    SEYMOUR, R
    AMERICAN JOURNAL OF PSYCHIATRY, 1989, 146 (10): : 1328 - 1330
  • [6] Treatment of obsessive-compulsive disorder with fluvoxamine: A multicentre, double-blind, placebo-controlled trial
    Goodman, WK
    Kozak, MJ
    Liebowitz, M
    White, KL
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 (01) : 21 - 29
  • [7] Double-blind, placebo-controlled trial of topiramate augmentation in the treatment of obsessive-compulsive disorder
    Berlin, Heather A.
    Koran, Lorrin M.
    Jenike, Michael A.
    Shapira, Nathan A.
    Chaplin, William
    Pallanti, Stefano
    Hollander, Eric
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 170S - 170S
  • [8] Gamma Ventral Capsulotomy for Obsessive-Compulsive Disorder A Randomized Clinical Trial
    Lopes, Antonio C.
    Greenberg, Benjamin D.
    Canteras, Miguel M.
    Batistuzzo, Marcelo C.
    Hoexter, Marcelo Q.
    Gentil, Andre F.
    Pereira, Carlos A. B.
    Joaquim, Marines A.
    de Mathis, Maria E.
    D'Alcante, Carina C.
    Taub, Anita
    de Castro, Douglas G.
    Tokeshi, Lucas
    Sampaio, Leonardo A. N. P. C.
    Leite, Claudia C.
    Shavitt, Roseli G.
    Diniz, Juliana B.
    Busatto, Geraldo
    Noren, Georg
    Rasmussen, Steven A.
    Miguel, Euripedes C.
    JAMA PSYCHIATRY, 2014, 71 (09) : 1066 - 1076
  • [9] Is quetiapine effective for obsessive and compulsive symptoms in patients with bipolar disorder? A randomized, double-blind, placebo-controlled clinical trial
    Sahraian, Ali
    Ghahremanpouri, Bahareh
    Mowla, Arash
    CNS SPECTRUMS, 2022, 27 (05) : 634 - 638
  • [10] Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial
    Noorbala, AA
    Hosseini, SH
    Mohammadi, MR
    Akhondzadeh, S
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (02) : 155 - 159
12345